Mode
Text Size
Log in / Sign up
N/A Completed N=1,004 Treatment

Implementing HEARTS in Guatemala

Source: ClinicalTrials.gov NCT06080451 ↗
Enrolled (actual)
1,004
Serious AEs
0.0%
Results posted
Jun 2025
Primary outcomePrimary: Score on Feasibility of Intervention Measure (FIM) Questionnaire — 5.0 score on a scale

Summary

The HEARTS Technical Package was developed by the World Health Organization to address the implementation gap of cardiovascular disease prevention in low- and middle-income countries. Guatemala is a middle-income country that is currently implementing HEARTS. National authorities are interested in exploring how hypertension and diabetes management can be integrated in HEARTS implementation. The objective of this study is to conduct a feasibility and acceptability pilot trial of integrated hypertension and diabetes management based on HEARTS in the publicly funded primary care system in Guatemala.

Outcome Measures

OutcomeResultp-value
PRIMARY
Score on Feasibility of Intervention Measure (FIM) Questionnaire
5.0
PRIMARY
Number of Target Health Districts That Met Enrollment Goals
2
PRIMARY
Score on Acceptability of Intervention Measure (AIM) Questionnaire
5.0
PRIMARY
Proportion of Patient Participants With Subsequent Follow-up Visit Within 3 Months
36
SECONDARY
Hypertension Treatment Rate
197
SECONDARY
Diabetes Treatment Rate
108
SECONDARY
Proportion of Patient Participants Achieving Glycemic Control
41
SECONDARY
Proportion Achieving Control of Blood Pressure
50.6
SECONDARY
Adoption
10
SECONDARY
Fidelity - Health Worker Training
20; 20
SECONDARY
Fidelity - Team-based Care and Task Sharing
10
SECONDARY
Fidelity - Access to Medicines and Diagnostics
49
SECONDARY
Fidelity - Facility-based Electronic Monitoring Tool
7.6
SECONDARY
Usability
67.7
SECONDARY
Sustainability
5.3
SECONDARY
Mean Systolic Blood Pressure
141.7
SECONDARY
Mean Diastolic Blood Pressure
81.5
SECONDARY
Fidelity - Chart Audit
SECONDARY
Fidelity - Systems Monitoring and Feedback

Eligibility Criteria

Patient participants

Inclusion criteria

  • Non-pregnant adults aged ≥18 years
  • Diagnoses of type 2 diabetes or hypertension
  • Present for routine care at participating MOH primary health facilities

Exclusion criteria

  • Confirmed or suspected type 1 diabetes
  • Pregnant
  • Are not managed at MOH health centers or health posts

Provider/other participants

Inclusion criteria

  • Participation in delivering HEARTS or on the Technical Advisory Committee

Exclusion criteria

  • None
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT06080451). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search